Sweet Dreams Ahead: FDA Approves Zepbound for the Treatment of Sleep Apnea!
FDA Approves Zepbound: A New Hope for Sleep Apnea Relief
Comprehensive Medical Weight Loss
Category tirzepatide
In clinical trials, tirzepatide, marketed as Zepbound for weight loss and as Mounjaro for diabetes, helped people lose an average of 20% of their body weight, or over 50 pounds!
Zepbound shortage over: An end to Compounded Tirzepatide
On Thursday, 12/19/2024, the FDA declared that tirzepatide (Zepbound / Mounjaro) is no longer in shortage. This will have significant impact for patients currently being treated with compounded tirzepatide. Read on to learn more about this decision, and about your…
How to stop a GLP-1 Weight Loss Medication
Tips to Gracefully Bid Farewell to GLP-1 Meds!
GLP-1 Updates: semaglutide / tirzepatide
It has been an exciting summer for our new GLP-1 weight loss medications, Wegovy (semaglutide) and Zepbound (tirzepatide). This information is current as of 9 Semaglutide At this time, all doses of Wegovy are available at retail pharmacies. Further, all…
